These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 23268419

  • 1. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
    Wang R, Xie J, Shen Y, Ren T.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1820-3. PubMed ID: 23268419
    [Abstract] [Full Text] [Related]

  • 2. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
    Yagi K, Nakamura A, Sekine A.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
    [Abstract] [Full Text] [Related]

  • 3. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
    Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL.
    Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
    [Abstract] [Full Text] [Related]

  • 4. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C, Going J, Neilson L, Mackay C, Stuart RC.
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [Abstract] [Full Text] [Related]

  • 5. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
    Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P.
    Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
    [Abstract] [Full Text] [Related]

  • 6. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
    Schilling D, Spiethoff A, Rosenbaum A, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer MH, Riemann JF.
    Pathol Res Pract; 2005 Apr; 200(11-12):801-5. PubMed ID: 15792123
    [Abstract] [Full Text] [Related]

  • 7. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR, Wickramasinghe KS, Lord RV, Friedman A, Balaji NS, Chandrasoma PT, Hagen JA, Peters JH, DeMeester TR.
    Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
    [Abstract] [Full Text] [Related]

  • 8. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA, Streutker CJ, Riddell RH.
    Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
    [Abstract] [Full Text] [Related]

  • 9. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.
    Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL.
    Hum Pathol; 1999 Mar; 30(3):288-94. PubMed ID: 10088547
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
    El-Zimaity HM, Graham DY.
    Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
    [Abstract] [Full Text] [Related]

  • 11. Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum.
    White NM, Gabril M, Ejeckam G, Mathews M, Fardy J, Kamel F, Doré J, Yousef GM.
    Can J Gastroenterol; 2008 Apr; 22(4):369-75. PubMed ID: 18414711
    [Abstract] [Full Text] [Related]

  • 12. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
    Liu GS, Gong J, Cheng P, Zhang J, Chang Y, Qiang L.
    World J Gastroenterol; 2005 Oct 28; 11(40):6360-5. PubMed ID: 16419166
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
    Çoban Ş, Örmeci N, Savaş B, Ekiz F, Ensari A, Kuzu I, Palabıyıkoğlu M.
    Dis Esophagus; 2013 Oct 28; 26(2):189-96. PubMed ID: 22591041
    [Abstract] [Full Text] [Related]

  • 14. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
    Pascarenco OD, Boeriu A, Mocan S, Pascarenco G, Drasoveanu S, Galeanu M, Dobru D.
    J Gastrointestin Liver Dis; 2014 Mar 28; 23(1):19-25. PubMed ID: 24689092
    [Abstract] [Full Text] [Related]

  • 15. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
    Morales TG, Bhattacharyya A, Johnson C, Sampliner RE.
    Am J Gastroenterol; 1997 Oct 28; 92(10):1818-22. PubMed ID: 9382043
    [Abstract] [Full Text] [Related]

  • 16. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia.
    Weston AP, Krmpotich P, Makdisi WF, Cherian R, Dixon A, McGregor DH, Banerjee SK.
    Am J Gastroenterol; 1996 May 28; 91(5):981-6. PubMed ID: 8633592
    [Abstract] [Full Text] [Related]

  • 17. Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barrett's oesophagus in Korea?
    Yim HJ, Lee SW, Choung RS, Kim YS, Kim JY, Lee HS, Song CW, Choi JH, Bak YT, Ryu HS, Hyun JH, Kim DS, Kim CH.
    Eur J Gastroenterol Hepatol; 2005 Jun 28; 17(6):611-6. PubMed ID: 15879722
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of cytokeratin immunoreactivity pattern for distinction of Barrett's esophagus from intestinal metaplasia of the stomach.
    Iwata T, Kurita N, Nishioka M, Hidenori M, Wakatsuki S, Sano T, Shimada M.
    Hepatogastroenterology; 2007 Sep 28; 54(78):1710-2. PubMed ID: 18019700
    [Abstract] [Full Text] [Related]

  • 19. Comparison of intestinal metaplasia in gastric cardia and Barrett's esophagus.
    Miao Q, Peng YS, Cai GH, Chen XY.
    J Dig Dis; 2011 Aug 28; 12(4):272-8. PubMed ID: 21791021
    [Abstract] [Full Text] [Related]

  • 20. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.
    Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Fléjou JF, Groupe d'Etude l'Oesophage de Barrett.
    Gut; 2001 Dec 28; 49(6):761-6. PubMed ID: 11709508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.